HRP20090513T1 - S-mirtazapin, namijenjen liječenju napadaja vrućine - Google Patents

S-mirtazapin, namijenjen liječenju napadaja vrućine

Info

Publication number
HRP20090513T1
HRP20090513T1 HR20090513T HRP20090513T HRP20090513T1 HR P20090513 T1 HRP20090513 T1 HR P20090513T1 HR 20090513 T HR20090513 T HR 20090513T HR P20090513 T HRP20090513 T HR P20090513T HR P20090513 T1 HRP20090513 T1 HR P20090513T1
Authority
HR
Croatia
Prior art keywords
mirtazapine
treatment
intended
hot weight
hot
Prior art date
Application number
HR20090513T
Other languages
English (en)
Croatian (hr)
Inventor
Bernardus Peeters B.W.M.M.
Egbert Peter Adang Anton
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090513(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of HRP20090513T1 publication Critical patent/HRP20090513T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
HR20090513T 2004-11-15 2005-11-14 S-mirtazapin, namijenjen liječenju napadaja vrućine HRP20090513T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
PCT/EP2005/055947 WO2006051111A1 (en) 2004-11-15 2005-11-14 S-mirtazapine for the treatment of hot flush

Publications (1)

Publication Number Publication Date
HRP20090513T1 true HRP20090513T1 (hr) 2009-10-31

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090513T HRP20090513T1 (hr) 2004-11-15 2005-11-14 S-mirtazapin, namijenjen liječenju napadaja vrućine

Country Status (30)

Country Link
US (4) US20070265245A1 (sr)
EP (1) EP1814555B1 (sr)
JP (1) JP2008519810A (sr)
KR (1) KR20070085470A (sr)
CN (2) CN101056641A (sr)
AR (1) AR053780A1 (sr)
AT (1) ATE439843T1 (sr)
AU (1) AU2005303778B2 (sr)
BR (1) BRPI0517818A2 (sr)
CA (1) CA2587283C (sr)
CY (1) CY1110538T1 (sr)
DE (1) DE602005016141D1 (sr)
DK (1) DK1814555T3 (sr)
ES (1) ES2329815T3 (sr)
HR (1) HRP20090513T1 (sr)
IL (1) IL182767A (sr)
MX (1) MX2007005827A (sr)
MY (1) MY144089A (sr)
NO (1) NO20072285L (sr)
NZ (1) NZ554858A (sr)
PE (1) PE20061051A1 (sr)
PL (1) PL1814555T3 (sr)
PT (1) PT1814555E (sr)
RS (1) RS51138B (sr)
RU (1) RU2396957C2 (sr)
SI (1) SI1814555T1 (sr)
TW (1) TW200631584A (sr)
UA (1) UA88655C2 (sr)
WO (1) WO2006051111A1 (sr)
ZA (1) ZA200703884B (sr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1898919A2 (en) * 2005-06-27 2008-03-19 N.V. Organon A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
CA2644985A1 (en) * 2006-03-06 2007-09-13 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
CA2669833A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
PT3261645T (pt) 2015-02-27 2021-06-17 Dechra Ltd Estimulação do apetite, gestão da perda de peso, e tratamento da anorexia em cães e gatos
KR102608479B1 (ko) * 2017-05-25 2023-12-01 글리테크 엘엘씨. Nmdar 길항제-반응성 신경정신 질환을 위한 병용 요법
US12564288B2 (en) 2020-02-19 2026-03-03 Ivan Ulinich Universal device for heat treating food products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
DK1067934T3 (da) * 1998-04-02 2004-03-29 Akzo Nobel Nv Flydende oral opløsning omfattende det anti-depressive middel mirtazapin
RU2195951C1 (ru) * 2001-08-20 2003-01-10 Общество с ограниченной ответственностью "Лаборатория "Ирис" Средство для лечения климактерических расстройств

Also Published As

Publication number Publication date
DK1814555T3 (da) 2009-12-07
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
CN102772414A (zh) 2012-11-14
RS51138B (sr) 2010-10-31
UA88655C2 (ru) 2009-11-10
MX2007005827A (es) 2007-07-20
MY144089A (en) 2011-08-15
EP1814555A1 (en) 2007-08-08
JP2008519810A (ja) 2008-06-12
IL182767A (en) 2011-07-31
PE20061051A1 (es) 2006-10-26
RU2396957C2 (ru) 2010-08-20
NZ554858A (en) 2009-10-30
BRPI0517818A2 (pt) 2010-03-16
AU2005303778A1 (en) 2006-05-18
HK1104235A1 (en) 2008-01-11
DE602005016141D1 (de) 2009-10-01
SI1814555T1 (sl) 2009-12-31
US20100267694A1 (en) 2010-10-21
US20070265245A1 (en) 2007-11-15
PL1814555T3 (pl) 2010-01-29
ATE439843T1 (de) 2009-09-15
CN101056641A (zh) 2007-10-17
RU2007122391A (ru) 2008-12-20
AU2005303778B2 (en) 2011-02-17
US20120302552A1 (en) 2012-11-29
CY1110538T1 (el) 2015-04-29
CA2587283A1 (en) 2006-05-18
NO20072285L (no) 2007-06-13
CA2587283C (en) 2013-01-15
EP1814555B1 (en) 2009-08-19
US20130225559A1 (en) 2013-08-29
PT1814555E (pt) 2009-09-30
IL182767A0 (en) 2007-09-20
TW200631584A (en) 2006-09-16
ES2329815T3 (es) 2009-12-01
KR20070085470A (ko) 2007-08-27
AR053780A1 (es) 2007-05-23

Similar Documents

Publication Publication Date Title
ATE461217T1 (de) Glp-1-verbindungen
NO20055516L (no) Kannabinoidreceptorligander og anvendelser derav
EA200802213A1 (ru) Способы лечения заболеваний крови
IL232313A0 (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the aforementioned
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
IS7814A (is) Fenetanólamín afleiða í meðhöndlun á öndunarfærasjúkdómum.
AU303120S (en) Photosensitive drum unit
IS7840A (is) 3-(3,5-díoxó-4,5-díhýdró-3H-(1,2,4)tríasín-2-ýl)-bensamíð afleiður sem P2X7-hindrar til notkunar í meðferð á bólguvaldandi sjúkdómum
UA85559C2 (en) Aminobenzophenone compounds
MY149705A (en) Pyridino-pyridinone derivatives, preparation therof, and therapeutic use thereof
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
NO20093542L (no) Inhibering av tumormetastase ved hjelp av anti-neuropilin 2-antistoffer
SG158133A1 (en) Method for reversing multiple resistance in animal cells
NO20055741L (no) Nye kjemiske forbindelser
SE0301650D0 (sv) Novel compounds
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
MX2007002917A (es) Todo-trans-retinol: todo-trans-13, 14-dihidrorretinol saturasa y metodos de uso de la misma.
DK1496918T3 (da) Anvendelse af natriummetaarsenit til behandling af tumorer
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
DK1713438T3 (da) Medicinsk sæbe
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
NO20063715L (no) Syntese av spongosin
RU2002117643A (ru) Люплатекс, обладающий противолучевыми свойствами